Periscope Capital’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-294,357
Closed -$2.94M 1091
2021
Q3
$2.94M Hold
294,357
0.09% 405
2021
Q2
$2.94M Sell
294,357
-599,500
-67% -$6M 0.1% 377
2021
Q1
$8.86M Buy
+893,857
New +$9.07M 0.35% 65

Other funds holding EQHA.U

Periscope Capital's EQHA.U Position: Q4 2021 in Review

Periscope Capital sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 294,357 shares — an estimated $2.94M sold.

Periscope Capital first reported a position in EQHA.U in Q1 2021 and held it in 3 quarters. The position peaked at $8.86M in Q1 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Periscope Capital reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Periscope Capital sold 294,357 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $2.94M.
  • Periscope Capital first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Periscope Capital's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $8.86M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Periscope Capital's 13F filing for Q4 2021, filed 14 Feb 2022.